journal article·2018-11-12Open access

Metal nanoparticles restrict the growth of protozoan parasites

Oluyomi Stephen Adeyemi, Nthatisi Innocentia Molefe, Oluwakemi Josephine Awakan, Charles Obiora Nwonuma, Omokolade Oluwaseyi Alejolowo, Tomilola Olaolu, Rotdelmwa Filibus Maimako, Keisuke Suganuma, Yongmei Han, Kentaro Kato

Abstract

The Trypanosoma and Toxoplasma spp, are etiological agents of diseases capable of causing significant morbidity, mortality and economic burden, predominantly in developing countries. Currently, there are no effective vaccines for the diseases caused by these parasites; therefore, therapy relies heavily on antiprotozoal drugs. However, the treatment options for these parasitic diseases are limited, thus underscoring the need for new anti-protozoal agents. Here, we investigated the anti-parasite action of nanoparticles. We found that the nanoparticles have strong and selective in vitro activity against T. b. brucei but moderate in vitro activity against T. congolense and T. evansi. An estimation of the in vitro anti-Trypanosoma efficacy showed that the nanoparticles had ≥200-fold selective activity against the parasite versus mammalian cells. Moreover, the nanoparticle alloys moderately suppressed the in vitro growth of T. gondii by ≥60%. In our in vivo study, the nanoparticles appeared to exhibit a trypanostatic effect, but did not totally suppress the rat parasite burden, thereby failing to appreciably extend the survival time of infected animals compared with the untreated control. In conclusion, this is the first study to demonstrate the selective in vitro anti-Trypanosoma action of nanoparticles and thus supports the potential of nanoparticles as alternative anti-parasitic agents.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Research on Leishmaniasis Studies · Toxoplasma gondii Research Studies · Trypanosoma species research and implications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Medicinal Biochemistry, Nanomedicine and Toxicology Laboratory, Department of Biological Sciences, Landmark University

National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine

Funding

International Foundation for Science · Japan Society for the Promotion of Science

References (42)

Show source-provided references
1. 10.1017/S003118201300081410.1017/S0031182013000814 ↗
2. 10.1515/jbcpp-2012-001810.1515/jbcpp-2012-0018 ↗
3. 10.2147/IJN.S12217810.2147/IJN.S122178 ↗
4. 10.3923/rjpharm.2010.74.7710.3923/rjpharm.2010.74.77 ↗
5. 10.1038/sj.bjp.070735410.1038/sj.bjp.0707354 ↗
6. 10.1086/43257610.1086/432576 ↗
7. 10.1016/j.imbio.2008.07.02310.1016/j.imbio.2008.07.023 ↗
8. 10.1007/s00436-017-5542-710.1007/s00436-017-5542-7 ↗
9. 10.1046/j.1365-3156.2001.00710.x10.1046/j.1365-3156.2001.00710.x ↗
10. World Health Organization. Control and surveillance of African trypanosomiasis: report of a WHO Expert Committee. World Health Organ Tech Rep Ser. 1998;881(I-VI):1–114.
11. 10.4061/2011/13570110.4061/2011/135701 ↗
12. 10.1128/MMBR.64.3.607-623.200010.1128/MMBR.64.3.607-623.2000 ↗
13. 10.1128/AAC.00868-1210.1128/AAC.00868-12 ↗
14. 10.7555/JBR.28.2013009610.7555/JBR.28.20130096 ↗
15. 10.1016/j.colsurfb.2011.03.00910.1016/j.colsurfb.2011.03.009 ↗
16. Lekshmi NCJ, Sumi SB, Viveka S, et al. Antibacterial activity of nanoparticles from Allium sp J. Microbiol Biotech Res. 2012;2:115–119.
17. Bhardwaj R, Saudagar P, Dubey VK. Nanobiosciences: a contemporary approach in antiparasitic drugs. Mol Cell Pharmacol. 2012;4:97–103.
18. 10.1007/s00253-013-4868-z10.1007/s00253-013-4868-z ↗
19. 10.1016/j.parint.2015.05.00410.1016/j.parint.2015.05.004 ↗
20. 10.1021/es903187s10.1021/es903187s ↗
21. Salma AA, Amer HA, Shaemaa HA, et al. The effects of gold and silver nanoparticles on transaminase enzymes activities. Int J Cancer. 2011;3:2249–2329.
22. 10.1289/ehp.110392810.1289/ehp.1103928 ↗
23. 10.1016/j.ijbiomac.2013.09.00810.1016/j.ijbiomac.2013.09.008 ↗
24. 10.1016/j.bbagen.2013.10.03810.1016/j.bbagen.2013.10.038 ↗
25. 10.1016/j.bbrep.2017.07.00410.1016/j.bbrep.2017.07.004 ↗
26. 10.1007/s00580-016-2274-510.1007/s00580-016-2274-5 ↗
27. 10.1016/j.matchemphys.2008.11.05610.1016/j.matchemphys.2008.11.056 ↗
28. 10.1166/jbn.2018.254410.1166/jbn.2018.2544 ↗
29. Sivaraman SK, Elango I, Kumar S, et al. A green protocol for room temperature synthesis of silver nanoparticles in seconds. Curr Sci. 2009;97:1055–1059.
30. 10.1017/S003118200006253310.1017/S0031182000062533 ↗
31. 10.1007/s00436-013-3608-810.1007/s00436-013-3608-8 ↗
32. Council for International Organizations of Medical Sciences. International guiding principles for biomedical research involving animals. Geneva, Switzerland: Council for International Organizations of Medical Sciences (CIOMS); 1985.
33. 10.1016/0014-4894(76)90110-710.1016/0014-4894(76)90110-7 ↗
34. Adeyemi OS, Ekanem JT, Sulyman F. Depletion of parasitaemia by halofantrine hydrochloride and artemether in rats infected with African trypanosomes. Afr J Pharm Pharmacol. 2009;3:432–438.
35. 10.1128/AEM.70.5.2848-2853.200410.1128/AEM.70.5.2848-2853.2004 ↗
36. 10.1016/j.exppara.2015.11.00410.1016/j.exppara.2015.11.004 ↗
37. 10.1039/C5RA13206A10.1039/C5RA13206A ↗
38. 10.12816/001792010.12816/0017920 ↗
39. 10.1080/21691401.2017.134592110.1080/21691401.2017.1345921 ↗
40. 10.1080/21691401.2017.134593010.1080/21691401.2017.1345930 ↗
41. 10.1016/j.jtumed.2014.03.00210.1016/j.jtumed.2014.03.002 ↗
42. 10.1292/jvms.11-003810.1292/jvms.11-0038 ↗